Cargando…

Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes

INTRODUCTION: Empagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, ameliorates hyperglycemia in patients with type 2 diabetes (T2D) by inducing sustained glucosuria. Empagliflozin treatment was previously associated with a transient increase in 24-h urine volume in Caucasian patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasui, Atsutaka, Lee, Ganghyuck, Hirase, Tetsuaki, Kaneko, Tatsuroh, Kaspers, Stefan, von Eynatten, Maximilian, Okamura, Tomoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104279/ https://www.ncbi.nlm.nih.gov/pubmed/29488164 http://dx.doi.org/10.1007/s13300-018-0385-5

Ejemplares similares

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial
por: Shimada, Akira, et al.
Publicado: (2018)

Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–III clinical trials
por: Yabe, Daisuke, et al.
Publicado: (2018)

Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
por: Yamamoto, Fumiko, et al.
Publicado: (2020)

Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial
por: Sone, Hirohito, et al.
Publicado: (2019)

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME(®) trial
por: Kadowaki, Takashi, et al.
Publicado: (2019)

Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study
por: Terauchi, Yasuo, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA(®) Trial
por: Watada, Hirotaka, et al.
Publicado: (2020)

Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial
por: Kaku, Kohei, et al.
Publicado: (2018)

Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2021)

THE EFFECT OF FLOOD DIURESIS ON HEMOGLOBINURIA
por: Haessler, Herbert
Publicado: (1922)

A Case of Hysteria with Diuresis
por: Fonceca, A. G.
Publicado: (1902)

Quinine Diuresis in Malarial Conditions
por: Heilig, Robert, et al.
Publicado: (1942)

Diuretin and Diuresis—The Theoretical Side
por: Richardson, Benjamin Ward
Publicado: (1894)

Massive Post-Obstructive Diuresis
por: Shankel, Stewart W.
Publicado: (2018)

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
por: Bjornstad, Petter, et al.
Publicado: (2018)

The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease
por: Kaku, Kohei, et al.
Publicado: (2022)

Healthcare resource utilization in patients treated with empagliflozin in East Asia
por: Sheu, Wayne H‐H, et al.
Publicado: (2022)

On the Diuresis Produced by Theocin in Healthy Persons
por: Dreser, H.
Publicado: (1904)

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
por: Cherney, David ZI, et al.
Publicado: (2014)

Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes
por: Ruggenenti, Piero, et al.
Publicado: (2021)

Balanced forced‐diuresis as a renal protective approach in cardiac surgery: Secondary outcomes of electrolyte changes
por: Luckraz, Heyman, et al.
Publicado: (2021)

Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database
por: Ono, Yasuhisa, et al.
Publicado: (2020)

Hypoxia briefly increases diuresis but reduces plasma volume by fluid redistribution in women
por: Roche, Johanna, et al.
Publicado: (2022)

Anti-diuresis in the management of daytime urinary incontinence
por: Robinson, D., et al.
Publicado: (2009)

Post-obstructive Diuresis: A Cautionary Tale
por: Singh, Amardeep, et al.
Publicado: (2019)

Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
por: Kinduryte Schorling, Ona, et al.
Publicado: (2020)

Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial
por: Luckraz, Heyman, et al.
Publicado: (2020)

Sodium artesunate-induced diuresis in a patient with malaria
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Sodium Content of the Renal Medulla During Osmotic Diuresis
por: Goodman, Alvin, et al.
Publicado: (1964)

Dissociation of natriuresis and diuresis by oxytocin molecular forms in rats
por: Jankowski, Marek, et al.
Publicado: (2019)

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
por: Adachi, Junichiro, et al.
Publicado: (2017)

Natural Mineral Water and Diuresis: A Systematic Review
por: Vitali, Matteo, et al.
Publicado: (2023)

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
por: Kohler, Sven, et al.
Publicado: (2017)

Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD‐Ib
por: Guerra, Fabiola, et al.
Publicado: (2023)

Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
por: Seino, Yutaka, et al.
Publicado: (2020)

First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis
por: Hunter, Robert W., et al.
Publicado: (2017)

Hypernatremia due to Urea-Induced Osmotic Diuresis: Physiology at the Bedside
por: Vadi, Sonali, et al.
Publicado: (2018)

The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children
por: Majd, Massoud, et al.
Publicado: (2018)

Impact of protocolized diuresis for de-resuscitation in the intensive care unit
por: Bissell, Brittany D., et al.
Publicado: (2020)

Physiologic approach to diuresis in de-resuscitation phase in intensive care
por: Lal, Amos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2j4p82rsn9ibmrn52ud24qdifs